|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen WQ, Zeng HM, Zheng RS, Zhang SW and
He J: Cancer incidence and mortality in China, 2007. Chin J Cancer
Res. 24:1–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zhang R, Zhang S, Zhao P, Li G, Wu
L and He J: Report of incidence and mortality in China cancer
registries, 2009. Chin J Cancer Res. 25:10–21. 2013.PubMed/NCBI
|
|
4
|
Chen WQ, Zheng RS, Zeng HM, Zhang SW, Zhao
P and Hao J: Trend analysis and projection of cancer incidence in
China between 1989 and 2008. Zhonghua Zhong Liu Za Zhi. 34:517–524.
2012.(In Chinese). PubMed/NCBI
|
|
5
|
Sjödahl K, Lu Y, Nilsen TI, Ye W, Hveem K,
Vatten L and Lagergren J: Smoking and alcohol drinking in relation
to risk of grastric cancer: A population-based, prospective cohort
study. Int J Cancer. 120:128–132. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Niccolai E, Taddei A, Prisco D and Amedei
A: Gastric cancer and the epoch of immunotherapy approaches. World
J Gastroenterol. 21:5778–5793. 2015.PubMed/NCBI
|
|
7
|
Xu W, Yang Z and Lu N: Molecular targeted
therapy for the treatment of gastric cancer. J Exp Clin Cancer Res.
35:12016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Miyazaki Y, Shibuya M, Sugawara H,
Kawaguchi O and Hirsoe C: Salinomycin, a new polyether antibiotic.
J Antibiot (Tokyo). 27:814–821. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Daugschies A, Gässlein U and Rommel M:
Comparative efficacy of anticoccidials under the conditions of
commercial broiler production and in battery trials. Vet Parasitol.
76:163–171. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Danforth HD, Ruff MD, Reid WM and Miller
RL: Anticoccidial activity of salinomycin in battery raised broiler
chickens. Poult Sci. 56:926–932. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mahmoudi N, de Julián-Ortiz JV, Ciceron L,
Gálvez J, Mazier D, Danis M, Derouin F and García-Domenech R:
Identification of new antimalarial drugs by linear discriminant
analysis and topological virtual screening. J Antimicrob Chemother.
57:489–497. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gupta PB, Onder TT, Jiang G, Tao K,
Kuperwasser C, Weinberg RA and Lander ES: Identification of
selective inhibitors of cancer stem cells by high-throughput
screening. Cell. 138:645–659. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Naujokat C, Fuchs D and Opelz G:
Salinomycin in cancer: A new mission for an old agent. Mol Med
Report. 3:555–559. 2010. View Article : Google Scholar
|
|
14
|
Kopp F, Hermawan A, Oak PS, Ulaganathan
VK, Herrmann A, Elnikhely N, Thakur C, Xiao Z, Knyazev P, Ataseven
B, et al: Sequential salinomycin treatment results in resistance
formation through clonal selection of epithelial-like tumor cells.
Transl Oncol. 7:702–711. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim JH, Chae M, Kim WK, Kim YJ, Kang HS,
Kim HS and Yoon S: Salinomycin sensitizes cancer cells to the
effects of doxorubicin and etoposide treatment by increasing DNA
damage and reducing p21 protein. Br J Pharmacol. 162:773–784. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiao Z, Sperl B, Ullrich A and Knyazev P:
Metformin and salinomycin as the best combination for the
eradication of NSCLC monolayer cells and their alveospheres (cancer
stem cells) irrespective of EGFR, KRAS, EML4/ALK and LKB1 status.
Oncotarget. 5:12877–12890. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Antoszczak M, Popiel K, Stefańska J,
Wietrzyk J, Maj E, Janczak J, Michalska G, Brzezinski B and
Huczyński A: Synthesis, cytotoxicity and antibacterial activity of
new esters of polyether antibiotic-salinomycin. Eur J Med Chem.
76:435–444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kopp F, Hermawan A, Oak PS, Herrmann A,
Wagner E and Roidl A: Salinomycin treatment reduces metastatic
tumor burden by hampering cancer cell migration. Mol Cancer.
13:162014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huczynski A: Salinomycin: A new cancer
drug candidate. Chem Biol Drug Des. 79:235–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boehmerle W, Muenzfeld H, Springer A,
Huehnchen P and Endres M: Specific targeting of neurotoxic side
effects and pharmacological profile of the novel cancer stem cell
drug salinomycin in mice. J Mol Med (Berl). 92:889–900. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schulte TW and Neckers LM: The
benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds
to Hsp90 and shares important biologic activities with
geldanamycin. Cancer Chemother Pharmacol. 42:273–279. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schnur RC, Corman ML, Gallaschun RJ,
Cooper BA, Dee MF, Doty JL, Muzzi ML, Moyer JD, DiOrio CI, Barbacci
EG, et al: Inhibition of the oncogene product p185erbB-2 in vitro
and in vivo by geldanamycin and dihydrogeldanamycin derivatives. J
Med Chem. 38:3806–3812. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen S, Chen X, Li Y, Yang S, Mo X, Zhang
F, Mo K and Ding Y: Inhibitory effect of 17-AAG combined with
paclitaxel on proliferation of esophageal squamous cell carcinoma
Eca-109 cells in vitro. Nan Fang Yi Ke Da Xue Xue Bao. 35:844–847.
2015.(In Chinese). PubMed/NCBI
|
|
24
|
Wu HH, Lin WC and Tsai KW: Advances in
molecular biomarkers for gastric cancer: miRNAs as emerging novel
cancer markers. Expert Rev Mol Med. 16:e12014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Song SP, Zhang XG, Wang M, et al: Changes
and significance of serum creatine kinase and isoenzymes in
salinomycin poisoning patients. Zhong Guo Wei Sheng Jian Yan Za
Zhi. 21:28–29. 2011.(In Chinese).
|
|
26
|
Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG,
Yoo HJ and Lee SJ: 17-Allylamino-17-demethoxygeldanamycin and
Herbimycin A induce cell death by modulating β-catenin and PI3K/AKT
signaling in FRO anaplastic thyroid carcinoma cells. Anticancer
Res. 35:5453–5460. 2015.PubMed/NCBI
|
|
27
|
Xu Y, Zhu Q, Chen D, Shen Z, Wang W, Ning
G and Zhu Y: The HSP90 inhibitor 17-AAG exhibits potent antitumor
activity for pheochromocytoma in a xenograft model. Tumour Biol.
36:5103–5108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
An H, Kim JY, Lee N, Cho Y, Oh E and Seo
JH: Salinomycin possesses anti-tumor activity and inhibits breast
cancer stem-like cells via an apoptosis-independent pathway.
Biochem Biophys Res Commun. 466:696–703. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhi QM, Chen XH, Ji J, Zhang JN, Li JF,
Cai Q, Liu BY, Gu QL, Zhu ZG and Yu YY: Salinomycin can effectively
kill ALDH(high) stem-like cells on gastric cancer. Biomed
Pharmacother. 65:509–515. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu PP, Zhu JC, Liu GX, Shui CX and Li XM:
Salinomycin enhances the apoptosis of T-cell acute lymphoblastic
leukemia cell line jurkat cells induced by vincristine. Zhongguo
Shi Yan Xue Ye Xue Za Zhi. 23:653–657. 2015.(In Chinese).
PubMed/NCBI
|
|
31
|
Zhang Y, Zuo Y, Guan Z, Lu W, Xu Z, Zhang
H, Yang Y, Yang M, Zhu H and Chen X: Salinomycin radiosensitizes
human nasopharyngeal carcinoma cell line CNE-2 to radiation. Tumor
Biol. 37:305–311. 2016. View Article : Google Scholar
|
|
32
|
Parajuli B, Lee HG, Kwon SH, Cha SD, Shin
SJ, Lee GH, Bae I and Cho CH: Salinomycin inhibits Akt/NF-κB and
induces apoptosis in cisplatin resistant ovarian cancer cells.
Cancer Epidemiol. 37:512–517. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cai Z, Tchou-Wong KM and Rom WN: NF-kappaB
in lung tumorigenesis. Cancers (Basel). 3:4258–4268. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu GZ, Pan CX, Jiang D, Zhang Q, Li Y and
Zheng SY: Clinicopathological significance of Fas and Fas ligand
expressions in esophageal cancer. Am J Cancer Res. 5:2865–2871.
2015.PubMed/NCBI
|
|
36
|
Liu W, Xu C, Zhao H, Xia P, Song R, Gu J,
Liu X, Bian J, Yuan Y and Liu Z: Osteoprotegerin induces apoptosis
of osteoclasts and osteoclast precursor cells via the fas/fas
ligand pathway. PLoS One. 10:e01425192015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Deng Y, Feng P, Chen D, et al: Effects of
Fas and Fas-L in cell apoptosis. Guo Wai Yi Xue Mian Yi Xue Fen Ce.
4:213–216. 1997.(In Chinese).
|
|
38
|
Wang Y, Wang C, Jiang C, Zeng H and He X:
Novel mechanism of harmaline on inducing G2/M cell cycle arrest and
apoptosis by up-regulating Fas/FasL in SGC-7901 cells. Sci Rep.
5:186132015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kong FC, Zhang JQ, Zeng C, Chen WL, Ren
WX, Yan GX, Wang HX, Li QB and Chen ZC: Inhibitory effects of
parthenolide on the activity of NF-κB in multiple myeloma via
targeting TRAF6. J Huazhong Univ Sci Technolog Med Sci. 35:343–349.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Diab S, Fidanzi C, Léger DY, Ghezali L,
Millot M, Martin F, Azar R, Esseily F, Saab A, Sol V, et al:
Berberis libanotica extract targets NF-κB/COX-2, PI3K/Akt and
mitochondrial/caspase signalling to induce human erythroleukemia
cell apoptosis. Int J Oncol. 47:220–230. 2015.PubMed/NCBI
|
|
41
|
Gmeiner WH, Jennings-Gee J, Stuart CH and
Pardee TS: Thymineless death in F10-treated AML cells occurs via
lipid raft depletion and Fas/FasL co-localization in the plasma
membrane with activation of the extrinsic apoptotic pathway. Leuk
Res. 39:229–235. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu W, Lin YT, Yan XL, Ding YL, Wu YL,
Chen WN and Lin X: Hepatitis B virus core protein inhibits
Fas-mediated apoptosis of hepatoma cells via regulation of
mFas/FasL and sFas expression. FASEB J. 29:1113–1123. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li L, Yao YC, Fang SH, Ma CQ, Cen Y, Xu
ZM, Dai ZY, Li C, Li S, Zhang T, et al: Pigment epithelial-derived
factor (PEDF)-triggered lung cancer cell apoptosis relies on p53
protein-driven Fas ligand (Fas-L) up-regulation and Fas protein
cell surface translocation. J Biol Chem. 289:30785–30799. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Parajuli B, Shin SJ, Kwon SH, Cha SD,
Chung R, Park WJ, Lee HG and Cho CH: Salinomycin induces apoptosis
via death receptor-5 up-regulation in cisplatin-resistant ovarian
cancer cells. Anticancer Res. 33:1457–1462. 2013.PubMed/NCBI
|
